CanVECTOR in the News

Latest CanVECTOR News
« Back to listings

CanVECTOR Awards Inaugural Clinical Research Coordinator of the Year


MONTREAL, November 5, 2021 – Today, CanVECTOR awarded the network's first Clinical Research Coordinator of the Year Award. Amanda Pecarskie of the Ottawa Hospital Research Institute (OHRI) has been named the recipient of the inaugural award.  Dr. Marc Rodger and Dr. Susan Kahn, CanVECTOR Co-Directors, announced the winner of the award at the CanVECTOR 2021 Annual Conference.

Ms. Pecarskie, a clinical research coordinator in thrombosis research, was nominated by multiple peers for her outstanding contributions to the thrombosis research program at OHRI. Ms. Pecarskie is recognized for not only her substantial impact on many successfully completed and ongoing clinical thrombosis studies but in particular her efforts in facilitating best practices, embracing and adapting to new challenges, and leading by example in an extremely challenging research environment during the COVID-19 pandemic. 

A few words from Ms. Pecarskie's nominators:

“What has made Amanda a standout especially in these past 1.5+ pandemic-era years is her unbound enthusiasm and persistence to show up to work be it in the clinic (even with restrictions) or consenting /following-up with study participants in new virtual ways.  Her work ethic has never slowed, and she is always the first to embrace new technologies and easily adapts to new situations in response to the ever-changing pandemic rules. Amanda has honed her clinical research coordinator skills to the benefit of investigators, research staff, and participants alike.  There is no other clinical research coordinator more deserving of this recognition offered by CanVECTOR."

“Amanda is the powerhouse of our thrombosis research program.”

Congratulations to Ms. Pecarskie! We are thrilled to amplify recognition of Ms. Pecarskie 's willingness to go above and beyond in her role, as well as for the dedication to various CanVECTOR studies during very difficult times.


There are currently no comments.

Log in to post a comment.